IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Global Blood Therapeutics in

Q2 2022 vs Q3 2022

Comparing institutional holders between quarters

Quarters

Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile
Maven Securities LTD
NEW
Shares128,600
Change+128,600
Value$8.8K
Filed 2022-11-16
Status
Maven Securities LTD
NEW128,600—+128,600——$8.8K—2022-11-16
Showing 1 of 1 institutions